Skip to main content
OpenTrials
Completed

NCT Number: NCT05857176

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Vaccine Adverse Reaction

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Rehab Hussein Werida

Damanhūr, Elbehairah, 31527, Egypt

About this study

  • A cross-sectional study was conducted. The subjects participating in the study are residents in Egypt.
  • An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).
  • The questionnaire comprised two categories of inquiries. The first is demographic data of the subject. The second is questions about COVID-19 vaccine-related data, such as whether had taken the vaccine or not, the type of vaccine administered, side effects encountered from the vaccine , if got enough information regarding the vaccine and where obtain the vaccine information from and if reluctant to taking the vaccine and the reasons for hesitancy. All participants were permitted to terminate the survey at any time of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all adults (age ≥ 18 years) complete the questionnaire were considered eligible to participate in the survey.

Exclusion criteria

  • Incomplete questionnaires were excluded from the final analysis.

Treatment and study plan

COVID-19 Vaccine questionnaire

Other

An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).

Other names: Google form questionnaire

Primary outcomes

  1. headache incidence

    Time frame: 3 month

    Pecentage

  2. fever incidence

    Time frame: 3 month

    Pecentage

  3. fatigue incidence

    Time frame: 3 month

    Pecentage

  4. pain at site of injection incidence

    Time frame: 3 month

    Pecentage

Sponsors and collaborators

Lead sponsor

Damanhour University

Other

Collaborators

  • Alexandria University

Registry information

Official study title

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines: A Cross-sectional Study.

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 12, 2023
Registry last updated
May 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.